Kringle Pharma (4884.T) Stock Price
Kringle Pharma Price
Revenue at Kringle Pharma has contracted by 31.2% per year over the past 5 years to 72.22 M JPY. For Kringle Pharma, the net margin of -1,268.8% is down versus -103.9% a few years ago.
Kringle Pharma stock price
Access this data via the Eulerpool API
100,000 free requests/mo · no credit card
Kringle Pharma business model & stock analysis
Frequently asked questions about Kringle Pharma
Converted at the current exchange rate, the Kringle Pharma share trades at 3.45 EUR (611.00 JPY).
The expected revenue of Kringle Pharma is 1.07 B JPY. This figure is based on current financial data and reflects the company's business performance.
The expected profit of Kringle Pharma is -147.00 M JPY. The net profit reflects the company's profitability after deducting all expenses.
The price-to-earnings ratio (P/E) of Kringle Pharma is currently -29.75. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Kringle Pharma stock.
The price-to-sales ratio (P/S) of Kringle Pharma is currently 4.10. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Kringle Pharma stock.
The Eulerpool Quality Score for Kringle Pharma is 2/10.
The ISIN of Kringle Pharma is JP3270790003. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The ticker of Kringle Pharma is 4884.T. The ticker symbol is used to trade Kringle Pharma shares on the stock exchange.
Kringle Pharma stock
Kringle Pharma Peer Group
Kringle Pharma FIGI
All fundamentals and in-depth analysis of Kringle Pharma
Our stock analysis for Kringle Pharma stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Kringle Pharma. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.